(Q41996129)

15 October 2017

Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor (English)

1 reference

15 October 2017

0 references

1 reference

1 reference

10.1136/JNNP.34.6.682

https://api.crossref.org/works/10.1136/JNNP.34.6.682

23 January 2024

author name string

H. L. Klawans

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

23 January 2024

S. P. Ringel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

23 January 2024

D. M. Shenker

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

23 January 2024

language of work or name

English

0 references

publication date

1 December 1971

1 reference

PMC publication ID

1083502

full work available at URL

15 October 2017

https://jnnp.bmj.com/content/jnnp/34/6/682.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

https://europepmc.org/articles/PMC1083502

23 January 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

https://europepmc.org/articles/PMC1083502?pdf=render

23 January 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5158783

https://syndication.highwire.org/content/doi/10.1136/jnnp.34.6.682

23 January 2024

1 reference

Crossref

DOI

10.1136/JNNP.34.6.682

https://api.crossref.org/works/10.1136/JNNP.34.6.682

Journal of Neurology, Neurosurgery and Psychiatry

23 January 2024

published in

1 reference

15 October 2017

34

1 reference

15 October 2017

6

1 reference

15 October 2017

682-686

1 reference

Aromatic L-amino acid decarboxylase

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Allosteric proteins and cellular control systems

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Genetic regulatory mechanisms in the synthesis of proteins

5 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

5 June 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Parkinsonism: onset, progression, and mortality

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

On the origin of homovanillic acid in the cerebrospinal fluid.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

The localization of monoaminergic blood-brain barrier mechanisms

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Treatment of Parkinsonism With Levodopa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Failure of pyridoxine to reduce drug-induced dyskinesias

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Dopamine (3-hydroxytyramine) and brain function

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Impairment of pyridoxal phosphate dependent metabolic reactions in a child with subacute necrotizing encephalopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

The pharmacology of parkinsonism (a review).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Theoretical implications of the use of L-dopa in parkinsonism. A review

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

A pharmacologic analysis of Huntington's chorea

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Modification of Parkinsonism--chronic treatment with L-dopa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083502

Dopa decarboxylase: substrates, coenzyme, inhibitors

5 June 2018

1 reference

12 December 2020

Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)

1 reference

12 December 2020

L-dopa and cerebrospinal fluid homovanillic acid in parkinsonism

1 reference

12 December 2020

The action of pyridoxine in primary hyperoxaluria

1 reference

12 December 2020

Pyridoxine reversal of L-dopa effects in Parkinsonism.

1 reference

12 December 2020

Cerebrospinal fluid 5-hydroxyindoles and behavior after l-tryptophan and pyridoxine administration to psychiatric patients

1 reference

12 December 2020

A method for evaluating disability in patients with Parkinson's disease.

1 reference

12 December 2020

[On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.34.6.682

1 reference

15 October 2017

1 reference

PMC publication ID

1083502

15 October 2017

1 reference

PMC publication ID

1083502